Powercaps for Women
Natural health product licensed in Canada
- Other names
- Nutramed for Strong Women
- Licence holder
- Nutramed Science Corporation
- NPN or DIN-HM
- 80087689
- Status
- Inactive licence
- Licence date
- 8 August 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Humulus lupulus Source : Humulus lupulus - Strobile Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 0.18 mg ÉAI Genistein | 150 mg | Not calculated |
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Dioscorea villosa Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 375 mg | 75 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine et stolon Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 0.75 g | 75 mg | Not calculated |
| Actaea racemosa Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Actaea racemosa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 320 mg | 80 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 500 UI | 12.5 mcg | Not calculated |
| Vitamine D Source : Ergocalciférol Potency : 500 UI | 12.5 mcg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 16.3 mg ÉAI Genistin | Not specified | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 40 mg ÉAI Isoflavones | Not specified | Not calculated |
Non-medicinal ingredients
Carbonate de calcium, Gélatine, Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to attenuate/reduce bone mineral density (BMD) loss in post-menopausal women when used in conjunction with adequate amounts of calcium and vitamin D. May reduce severe and frequent menopausal symptoms. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes. Licorice is traditionally used in Herbal Medicine as an expectorant to help relieve chest complaints, such as catarrhs, coughs and bronchitis. Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults. (Traditionally) used in Herbal Medicine to help relieve the pain associated with menstruation. (Traditionally) used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and of pain associated with neuralgia (such as sciatica). (Traditionally) used in Herbal Medicine to help ease nervous tension (calmative). (Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. A factor in the maintenance of good health. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you are pregnant. Do not use if you have hormone sensitive conditions such as uterine, endometrial, breast, or ovarian cancer as well as endometriosis and uterine fibroids. Do not use if you have a protein S deficiency as wild yam may increase the risk of thrombosis.
Source
Official Health Canada record, licence 80087689
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.